Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
47.86
-0.13 (-0.27%)
At close: Dec 5, 2025, 4:00 PM EST
47.98
+0.12 (0.25%)
After-hours: Dec 5, 2025, 7:59 PM EST
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Jun 30, 2025 | 33.25B | 12.33B | 3.09B |
| Mar 31, 2025 | 33.03B | 11.32B | 2.94B |
| Dec 31, 2024 | 32.24B | 10.16B | 2.91B |
| Sep 30, 2024 | 30.91B | 8.58B | 2.73B |
| Jun 30, 2024 | 30.07B | 7.55B | 2.63B |
| Mar 31, 2024 | 28.47B | 6.99B | 2.65B |
| Dec 31, 2023 | 27.06B | 6.50B | 2.68B |
| Sep 30, 2023 | 25.14B | 5.60B | 2.72B |
| Jun 30, 2023 | 24.14B | 4.36B | 2.91B |
| Mar 31, 2023 | 22.97B | 3.32B | 3.08B |
| Dec 31, 2022 | 21.77B | 2.63B | 3.20B |
| Sep 30, 2022 | 20.74B | 2.16B | 3.18B |
| Jun 30, 2022 | 19.59B | 1.86B | 3.09B |
| Mar 31, 2022 | 18.60B | 1.60B | 3.06B |
| Dec 31, 2021 | 17.66B | 1.31B | 3.00B |
| Sep 30, 2021 | 16.48B | 1.12B | 2.96B |
| Jun 30, 2021 | 15.71B | 969.81M | 3.00B |
| Mar 31, 2021 | 15.39B | 884.00M | 2.98B |
| Dec 31, 2020 | 15.16B | 886.03M | 2.99B |
| Sep 30, 2020 | 15.69B | 943.13M | 3.12B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.